Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

39.05p
   
  • Change Today:
    -0.45p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 403,844
  • Market Cap: £211.02m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.5% 0.0%
Div Cover 2.4 4.2
Op Mrgn 6.3% 22.0%
ROCE 16.2%  
Latest F'cast
P/E 9.2 8.7
PEG n/a 1.8
Pr/Revenue 1.3 1.2
Pr/Book 0.7  
Latest F'cast
Revenue 2.6% 9.0%
PBT -71.3% 670.3%
EPS -33.0% 4.8%
DPS 5.0% -39.2%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 5.21 4.28p 12.4 n/a -33% 1.78p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 182.43 40.12 4.48p 8.8 1.9 +5% 1.08p 0.0%
31-Dec-24 194.68 39.07 4.47p 8.8 n/a -0% 0.94p 0.0%
31-Dec-25 208.16 41.36 5.14p 7.7 0.5 +15% 0.98p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 04-Mar-2024 08:00 RNS
Notification of Full Year Results 04-Mar-2024 07:00 RNS
New Chair Appointment 05-Feb-2024 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 39.05p
Change Today -0.45p
% Change -1.14 %
52 Week High 71.80
52 Week Low 34.50
Volume 403,844
Shares Issued 540.40m
Market Cap £211.02m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.58% above the market average79.58% above the market average79.58% above the market average79.58% above the market average79.58% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.77% below the market average67.77% below the market average67.77% below the market average67.77% below the market average67.77% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Income
8.33% below the market average8.33% below the market average8.33% below the market average8.33% below the market average8.33% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
89.08% below the market average89.08% below the market average89.08% below the market average89.08% below the market average89.08% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 28-Mar-2024

Time Volume / Share Price
12:31 1,942 @ 39.05p
12:31 4,247 @ 39.10p
12:31 2,736 @ 39.10p
12:29 30,000 @ 39.15p
12:26 4,212 @ 39.05p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page